Amneal Pharmaceuticals (AMRX) Finished Goods (2017 - 2020)

Amneal Pharmaceuticals' Finished Goods history runs 4 years deep, the most recent figure standing at $222.2 million for Q1 2020.

• In Q1 2020, Finished Goods changed N/A year-over-year to $222.2 million; the TTM figure through Mar 2020 stood at $222.2 million (changed N/A YoY), while the FY2019 annual figure was $150.7 million, down 31.93% from the prior year.
• Finished Goods was $222.2 million for Q1 2020 at Amneal Pharmaceuticals, up from $150.7 million in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $250.6 million in Q2 2018 to a low of $105.8 million in Q4 2017.
• Historically, Finished Goods has averaged $193.7 million across 4 years, with a median of $208.7 million in 2018.
• The sharpest annual moves came in 2018 and 2019: Finished Goods soared 109.19% in 2018, then plunged 31.93% in 2019.
• A 4-year view of Finished Goods shows it stood at $105.8 million in 2017, then surged by 109.19% to $221.4 million in 2018, then sank by 31.93% to $150.7 million in 2019, then jumped by 47.4% to $222.2 million in 2020.
• The last three Finished Goods figures came in at $222.2 million (Q1 2020), $150.7 million (Q4 2019), and $168.2 million (Q3 2019), per Business Quant data.